Novonesis
About Novonesis
Novonesis was formed on 29 January 2024 through the merger of two long-established multinational biotechnology companies: Novozymes and Chr. Hansen. Headquartered in Copenhagen, Denmark, Novonesis is a global leader ushering in a new era of biological solutions.Built on a century of innovation, we harness the power of microbiology and technology to transform how the world produces, consumes and lives. Our biological solutions deliver value to countless consumers and benefit the planet across more than 30 industries. Our over 10,000 employees worldwide work closely with partners and customers to drive business transformation via biotechnology.
Company facts
| Country | China |
|---|---|
| Region | Asia |
| Type | Manufacturer |
| City | Beijing |
Ratings & Reviews
Be the first to rate this supplier. Your feedback helps buyers worldwide source with confidence.
Related Industry Insights
Research, market data and analysis from the GlobalPetIndex editorial desk.
Trademark & ownership: The company names, brands, logos, trademarks, and proprietary information shown on this page are owned by their respective companies and rights holders. They are displayed for information indexing and reference only and do not imply endorsement, affiliation, or authorization. If you believe any content infringes your rights, please contact us at hello@globalpetindex.com with proof of ownership and the relevant URL(s). We will review and remove or update the content promptly upon receiving a valid notice.